Market cap
$1 Mln
Revenue (TTM)
$59 Mln
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
Market cap ($ Mln) |
1 | 16,969 |
Revenue ($ Mln) |
59 | 4,126 |
Net Profit ($ Mln) |
-54.61 | 543.90 |
Net Margin (%) |
-92.76 | 13.18 |
RoE (%) |
-2,210.94 | 10.78 |
Price to Earnings |
-- | 31.54 |
Price-To-Book |
0.22 | 3.24 |
Income Statement ($ Mln)
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Operating Revenue
|
58.88 | 4,126.40 |
|
Cost of Revenue
|
20.98 | 1,947.00 |
|
Gross Profit
|
44.31 | 2,227.80 |
|
Operating Expenses
|
72.63 | 1,457.80 |
|
Operating Profit (EBIT)
|
-34.74 | 721.60 |
|
Other Income
|
0.00 | 0.00 |
|
Profit before Tax
|
-54.35 | 663.60 |
|
Provision for Tax
|
0.33 | 119.70 |
|
Profit after Tax (Net Income)
|
-54.61 | 543.90 |
|
Minority Interest
|
0.06 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 |
Liabilities ($ Mln)
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Shareholder's Funds
|
2.67 | 5,245.10 |
|
Minority Interest
|
0.06 | 0.00 |
|
Non-Current Liabilities
|
7.84 | 2,984.30 |
|
Current Liabilities
|
50.65 | 951.30 |
|
Total Liabilities
|
68.18 | 9,156.00 |
Assets ($ Mln)
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Non-Current Assets
|
15.80 | 5,337.30 |
|
Current Assets
|
45.82 | 3,843.40 |
|
Total Assets
|
68.18 | 9,156.00 |
|
Total Debt*
|
32.67 | 2,520.30 |
|
Net Current Assets
|
-4.83 | 2,892.10 |
Cashflow ($ Mln)
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Cash From Operating Activities
|
-11.07 | 1,285.20 |
|
Cash Flow from Investing Activities
|
-0.12 | -781.00 |
|
Cash from Financing Activities
|
10.06 | -1,108.60 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
ROCE (%)
|
-84.62 | 10.05 |
|
ROE (%)
|
-2,210.94 | 10.78 |
|
ROA (%)
|
-51.52 | 5.48 |
|
EBIT Margin (%)
|
-83.67 | 18.46 |
|
Net Margin (%)
|
-92.76 | 13.18 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 |
Growth Ratios
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Revenue Growth (%)
|
-12.39 | 2.16 |
|
EBIT Growth (%)
|
-52.02 | -27.30 |
|
Net Profit Growth (%)
|
-8.91 | -26.90 |
|
EPS Growth (%)
|
11.68 | -23.75 |
|
Book Value Growth (%)
|
3.20 | 12.91 |
Valuation Ratios
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Price / Earnings
|
-0.03 | 24.35 |
|
Price / Book Value
|
0.69 | 3.75 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
-1.12 | 15.08 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Debt to Equity
|
1.87 | 0.48 |
|
Short term debt to equity ratio
|
9.85 | 0.00 |
|
Current Ratio
|
0.90 | 4.04 |
|
Quick Ratio
|
0.47 | 3.32 |
|
Interest Coverage
|
-9.69 | 7.97 |
Operating Efficiency Ratios
| Venus Concept (VERO) | Hologic (HOLX) | |
|---|---|---|
|
Debtors to sales (%)
|
28.69 | 14.16 |
|
Asset Turnover
|
0.56 | 0.42 |
|
Receivable days
|
140.57 | 55.55 |
|
Inventory Days
|
411.36 | 131.45 |
|
Payable days
|
138.10 | 38.40 |
|
Cash Conversion Cycle
|
413.83 | 148.60 |